Prader-willi Syndrome
📧 Sign up to get email alerts when something new happens for Prader-willi Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-03-17FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW
This clinical trial update reports the completion of a study examining sleep abnormalities in individuals with Rett syndrome, Angelman syndr…
-
CLINICAL_TRIALS research · 2015-12-16Clinical Trial Update: Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome [Phase 1]
Phase 1 clinical trial update exploring deep brain stimulation to treat obesity in patients with Prader-Willi syndrome.
-
CLINICAL_TRIALS trial_result · 2015-12-09Clinical Trial Update: Liraglutide Use in Prader-Willi Syndrome [Phase 4]
A Phase 4 trial evaluating liraglutide for Prader-Willi syndrome (with Type 2 diabetes mellitus) has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Macronutrient Regulation of Ghrelin and Peptide YY [NA]
The trial investigating macronutrient regulation of ghrelin and peptide YY (NCT02464514) has completed, with obesity and Prader-Willi syndro…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2015-06-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals, likely to update labeling or expand indicati…
-
FDA approval · 2015-05-26FDA Approved: NUTROPIN AQ NUSPIN 10 — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for Nutropin AQ Nuspin 10 (somatropin) from Genentech, adding/confirming a formulation strength unde…
-
FDA approval · 2015-01-23FDA Approved: NORDITROPIN — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Norditropin (somatropin) from Novo Nordisk, resulting in an approved supplemental indication/lab…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Hypoglycemia in Prader-Willi Syndrome
This entry reports the completion of a clinical trial investigating hypoglycemia in individuals with Prader-Willi syndrome, sponsored by the…
-
CLINICAL_TRIALS research · 2014-09-22Clinical Trial Update: Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
An observational study detailing characteristics of Prader-Willi syndrome and early-onset morbid obesity (NCT00375089) conducted by the Univ…
-
FDA approval · 2014-07-30FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humatrope (somatropin) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS) [NA]
The clinical trial evaluating octreotide therapy in children and young adults with Prader-Willi Syndrome was terminated. Results for the stu…
-
CLINICAL_TRIALS research · 2014-02-10Clinical Trial Update: Family-based Intervention for Youth With Prader-Willi Syndrome: The Active Play at Home Study [NA]
This entry describes a clinical trial focusing on a family-based intervention (Active Play at Home) for youth with Prader-Willi syndrome. It…
-
CLINICAL_TRIALS trial_result · 2013-05-01Clinical Trial Update: Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome [NA]
This clinical trial update notes the completion of a study investigating treatment for self-injurious behavior in individuals with Prader-Wi…
-
FDA approval · 2013-04-19FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA supplemental approval for Genotropin (somatropin) from Pfizer, authorizing an approved supplemental application to modify or expand its …
-
FDA approval · 2013-04-04FDA Approved: OMNITROPE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for Omnitrope (somatropin) from Sandoz Inc, potentially expanding or updating the product’s labe…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
A completed clinical trial evaluating plasma adiponectin levels and sleep architecture in children with Prader-Willi syndrome. The study pop…
-
CLINICAL_TRIALS trial_result · 2012-02-01Clinical Trial Update: The Intestinal Function in People With Prader-Willi Syndrome
This document reports the completion of a clinical trial assessing intestinal function in individuals with Prader-Willi syndrome.
-
CLINICAL_TRIALS trial_result · 2011-11-24Clinical Trial Update: Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome
A completed clinical trial assessed plasma adiponectin levels and vascular endothelial and smooth muscle cell function in children with Prad…
-
CLINICAL_TRIALS trial_result · 2011-08-08Clinical Trial Update: Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project [Phase 1, Phase 2]
A completed pilot study evaluating behavioral treatment for obsessive-compulsive symptoms in youth with Prader-Willi syndrome (Phase 1/Phase…
-
CLINICAL_TRIALS research · 2011-07-28Clinical Trial Update: Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity
A completed clinical trial update characterizing transcriptional regulators of ghrelin associated with genetic obesity, studied in Prader-Wi…
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
A completed clinical trial examined cortisol activity in individuals with Prader-Willi syndrome compared to healthy controls. The update not…
-
FDA approval · 2010-07-28FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMATROPE (somatropin) submitted by Eli Lilly and Company, authorizing changes to the existing p…
-
FDA approval · 2010-04-12FDA Approved: ZOMACTON — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for ZOMACTON (somatropin) from Ferring Pharmaceuticals Inc. The action represents an additional regu…
-
FDA approval · 2010-02-02FDA Approved: GENOTROPIN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Genotropin (somatropin) from Pfizer Laboratories Div Pfizer Inc.